Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
letter
. 2014 Jun;58(6):3566–3567. doi: 10.1128/AAC.02510-13

Detection of OXA-370, an OXA-48-Related Class D β-Lactamase, in Enterobacter hormaechei from Brazil

Jorge L M Sampaio a,b, Vanessa B Ribeiro c, Juliana Coutinho Campos a, Franciéli P Rozales c,d, Cibele M Magagnin c, Diego R Falci e, Renato Cassol F da Silva e, Micheline G Dalarosa e, Daniela I Luz c, Fabiane J Vieira c, Laura C Antochevis c, Afonso Luis Barth c,d, Alexandre P Zavascki f,g,
PMCID: PMC4068428  PMID: 24709259

LETTER

The class D β-lactamase OXA-48 (1) and its variants have emerged as important determinants of carbapenem resistance in Enterobacteriaceae, representing a public health concern in some countries (24). The objective of this study was to report a new OXA-48 variant.

In May 2013, the 87F-2 strain, initially identified as Enterobacter cloacae complex by a Vitek 2 system (bioMeriéux), was recovered from a rectal swab collected from an adult patient in an intensive care unit of a tertiary-care hospital in Porto Alegre, Brazil, in a routine surveillance for carbapenem-resistant Enterobacteriaceae. As the strain presented reduced susceptibility to imipenem and resistance to ertapenem (Table 1), according to the CLSI (5), a multiplex real-time PCR for detecting blaOXA-48, blaGES, blaKPC, blaVIM, blaNDM, and blaIMP genes (6) was performed and revealed the presence of a blaOXA-48-like gene.

TABLE 1.

MICs for Enterobacter hormaechei strain 87F-2, E. coli TOP10–p87F2 carrying blaOXA-370, and E. coli TOP10a

Antimicrobial MIC (μg/ml)
E. hormaechei (87F-2) E. coli TOP10–p87F2 carrying blaOXA-370 E. coli TOP10
IMP 1.5 0.5 0.25
MEM 0.5 0.064 0.032
ERT 4 0.032 0.008
DOR 0.38 0.047 0.023
PTZ >256 64 3
FEP 48 4 0.047
FEP/CLA >4 0.064 0.064
CAZ >256 2 0.38
CAZ/CLA >4 0.50 0.19
CTX >256 4 0.064
CTX/CLA >1 0.094 0.064
CRO >32 >32 0.094
ATM 96 4 0.0125
SAM >256 48 3
CIP 0.5 0.003 0.006
LVX 0.5 0.006 NP
GEN 0.38 0.25 0.25
AMK 1.5 1.5 3
PMB 0.19 0.125 0.25
CST 0.38 0.125 0.19
TGC 0.38 0.125 0.25
FOS 24 1 0.5
a

MICs with were assessed by Etest. IMP, imipenem; MEM, meropenem; ERT, ertapenem; DOR, doripenem; PTZ, piperacillin-tazobactam; FEP, cefepime; FEP/CLA, cefepime plus clavulanic acid; CAZ, ceftazidime; CAZ/CLA, ceftazidime plus clavulanic acid; CTX, cefotaxime; CTX/CLA, cefotaxime plus clavulanic acid; CRO, ceftriaxone; ATM, aztreonam; SAM, ampicillin-sulbactam; CIP, ciprofloxacin; LVX, levofloxacin; GEN, gentamicin; AMK, amikacin; PMB, polymyxin B; CST, colistin; TGC, tigecycline; FOS, fosfomycin; NP, not performed.

Plasmidial DNA (7) was electroporated into Escherichia coli Top10 (Life Technologies). Transformants were selected on LB agar containing ceftazidime (0.5 μg/ml). The presence of blaOXA-48-like was confirmed by amplification of a 755-bp fragment by PCR and sequencing using Sanger's chemistry and primers oxa-48-JS-fw (5′-GGCTGTGTTTTTGGTGGCAT) and oxa-48-JS-rv (5′-TGAGCACTTCTTTTGTGATGGC).

Species identification was also determined by partial sequencing of gyrB (8). When the obtained sequence (GenBank KJ488944.1) was compared to those from type strains made available at GenBank by Brady et al. (8), the highest similarity index (96.9%) was observed in comparison to Enterobacter hormaechei CCUG 27126 (GenBank accession JX424983.1).

Agarose gel electrophoresis of plasmid extraction (3) from transformants (E. coli TOP10–p87F2) evidenced a single plasmid of approximately 150 kbp. This plasmid was fully sequenced using Ion Torrent (Life Technologies) and preliminarily assembled using SeqMan NGen 4.0 (DNASTAR). Comparison of nucleotide sequences from contigs to those available at GenBank evidenced a tra operon with highest similarity to those found in IncF plasmids and also revealed the presence of blaTEM-1, blaCTX-M-8, and a new blaOXA-48 variant gene which was designated blaOXA-370 (http://www.lahey.org/studies/). The nucleotide sequences of blaOXA-370 and its genetic context were deposited in GenBank. This gene differed from blaOXA-48 by three nucleotides, but only substitutions 634T→G and 635C→A resulted in a unique amino acid substitution, S220E, according to class D β-lactamase numbering (9).

Contrasting to the blaOXA-48 genetic environment, which has the IS1999 upstream of the open reading frame (ORF) at the promoter region, the blaOXA-370 was flanked upstream by a Tn3 family tnpA gene truncated at 3′ by insertion of an IS5075-like insertion sequence (IS). The blaOXA-370 was flanked downstream by a Tn4 family tnpA gene truncated at 5′ by insertion of an IS15-like IS (Fig. 1). Similarly to blaOXA-48, predicted −10 and −35 promoter region signals were located 121 and 98 bp upstream of the blaOXA-370 start codon, respectively.

FIG 1.

FIG 1

Genetic context of blaOXA-370. Vertical bars represent the inverted repeats of IS5075. Note the absence of Tn1999.

MICs of the wild-type strain 87F-2, E. coli TOP10–p87F2, and E. coli TOP10 were assessed by Etest and are shown in Table 1.

A total of 10 OXA-48 variants, including OXA-370, have been described to date, some of them, e.g., OXA-163 and OXA-247, with no carbapenem-hydrolyzing activity (24, 10, 11). Although the hydrolytic profile of OXA-370 was not evaluated in this study, the transformant was susceptible to carbapenems and the MICs for ceftazidime, cefotaxime, and cefepime were reduced when clavulanate was added, suggesting that the increased MICs for these cephalosporins might be due to the expression of CTX-M-8. Indeed, only the piperacillin MIC was high in the transformant, even in the presence of tazobactam, which is compatible with the piperacillin-hydrolyzing activity of OXA-48 (1). Nonetheless, appropriate kinetic evaluation of OXA-370 must be further performed to define its hydrolytic profile.

In summary, we described a new OXA-48 variant, the OXA-370 variant, and this is the first report of an OXA-48-like variant in Brazil. The role of this new enzyme in the carbapenem-resistant phenotype should be further evaluated.

Nucleotide sequence accession numbers.

The nucleotide sequences of blaOXA-370 and its genetic context were deposited in GenBank under accession numbers KF900153.1 and KJ488943.1.

ACKNOWLEDGMENTS

We thank Laurent Poirel for sending us the OXA-48-producing reference strain and Roberto Matusiak for his important contributions to the experiments.

This work was supported by Fundo de Incentivo à Pesquisa e Eventos do Hospital de Clínicas de Porto Alegre, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, and Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil.

We declare that we have no conflicts of interest.

Footnotes

Published ahead of print 7 April 2014

REFERENCES

  • 1.Poirel L, Heritier C, Tolun V, Nordmann P. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15–22. 10.1128/AAC.48.1.15-22.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gomez S, Pasteran F, Faccone D, Bettiol M, Veliz O, De Belder D, Rapoport M, Gatti B, Petroni A, Corso A. 2013. Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae. Clin. Microbiol. Infect. 19:E233–E235. 10.1111/1469-0691.12142 [DOI] [PubMed] [Google Scholar]
  • 3.Oteo J, Hernandez JM, Espasa M, Fleites A, Saez D, Bautista V, Perez-Vazquez M, Fernandez-Garcia MD, Delgado-Iribarren A, Sanchez-Romero I, Garcia-Picazo L, Miguel MD, Solis S, Aznar E, Trujillo G, Mediavilla C, Fontanals D, Rojo S, Vindel A, Campos J. 2013. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. J. Antimicrob. Chemother. 68:317–321. 10.1093/jac/dks383 [DOI] [PubMed] [Google Scholar]
  • 4.Poirel L, Potron A, Nordmann P. 2012. OXA-48-like carbapenemases: the phantom menace. J. Antimicrob. Chemother. 67:1597–1606. 10.1093/jac/dks121 [DOI] [PubMed] [Google Scholar]
  • 5.CLSI. 2013. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document M100–S23 Clinical and Laboratory Standards Institute, Wayne, PA [Google Scholar]
  • 6.Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S. 2012. Rapid detection of carbapenemase genes by multiplex real-time PCR. J. Antimicrob. Chemother. 67:906–909. 10.1093/jac/dkr563 [DOI] [PubMed] [Google Scholar]
  • 7.Birnboim HC, Doly J. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513–1523. 10.1093/nar/7.6.1513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Brady C, Cleenwerck I, Venter S, Coutinho T, De Vos P. 2013. Taxonomic evaluation of the genus Enterobacter based on multilocus sequence analysis (MLSA): proposal to reclassify E. nimipressuralis and E. amnigenus into Lelliottia gen. nov. as Lelliottia nimipressuralis comb. nov. and Lelliottia amnigena comb. nov., respectively, E. gergoviae and E. pyrinus into Pluralibacter gen. nov. as Pluralibacter gergoviae comb. nov. and Pluralibacter pyrinus comb. nov., respectively, E. cowanii, E. radicincitans, E. oryzae and E. arachidis into Kosakonia gen. nov. as Kosakonia cowanii comb. nov., Kosakonia radicincitans comb. nov., Kosakonia oryzae comb. nov. and Kosakonia arachidis comb. nov., respectively, and E. turicensis, E. helveticus and E. pulveris into Cronobacter as Cronobacter zurichensis nom. nov., Cronobacter helveticus comb. nov. and Cronobacter pulveris comb. nov., respectively, and emended description of the genera Enterobacter and Cronobacter. Syst. Appl. Microbiol. 36:309–319. 10.1016/j.syapm.2013.03.005 [DOI] [PubMed] [Google Scholar]
  • 9.Couture F, Lachapelle J, Levesque RC. 1992. Phylogeny of LCR-1 and OXA-5 with class A and class D beta-lactamases. Mol. Microbiol. 6:1693–1705. 10.1111/j.1365-2958.1992.tb00894.x [DOI] [PubMed] [Google Scholar]
  • 10.Zong Z. 2012. Discovery of bla(OXA-199), a chromosome-based bla(OXA-48)-like variant, in Shewanella xiamenensis. PLoS One 7:e48280. 10.1371/journal.pone.0048280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Poirel L, Castanheira M, Carrer A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P. 2011. OXA-163, an OXA-48-related class D beta-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 55:2546–2551. 10.1128/AAC.00022-11 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES